Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

BACKGROUND: A three-drug regimen (macrolide, ethambutol, and rifampicin) is recommended for the treatment of Mycobacterium avium complex pulmonary disease (MAC-PD). Although macrolide has proven efficacy, the role of ethambutol and rifampicin in patients without acquired immune deficiency syndrome i...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:BMC Pulm Med
Main Authors: Kim, Hyung-Jun, Lee, Jong Sik, Kwak, Nakwon, Cho, Jaeyoung, Lee, Chang-Hoon, Han, Sung Koo, Yim, Jae-Joon
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2019
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849249/
https://ncbi.nlm.nih.gov/pubmed/31711459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12890-019-0982-8
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki